A nested case-control study of BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines for preventing death in individuals, using national population data
Latest Information Update: 12 Oct 2022
At a glance
- Drugs AZD 1222 (Primary) ; Coronavirus vaccine-Wuhan Institute of Biological Products (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 12 Oct 2022 New trial record
- 28 Sep 2022 Results published in the Vaccine